Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 1989;14:191-202

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Adams, M. A.
Right arrow Articles by Korner, P. I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Adams, M. A.
Right arrow Articles by Korner, P. I.

Hypertension, Vol 14, 191-202, Copyright © 1989 by American Heart Association


ARTICLES

Differential development of vascular and cardiac hypertrophy in genetic hypertension. Relation to sympathetic function

MA Adams, A Bobik and PI Korner
Baker Medical Research Institute, Melbourne, Australia.

We compared blood pressure, hindquarter vascular resistance properties, left ventricular weight, and norepinephrine kinetics, in spontaneously hypertensive rats (SHR) and weight-matched normotensive Wistar-Kyoto (WKY) rats at 4, 9, 14, 20, 30, and 50 weeks of age. At 4 weeks, systolic and mean blood pressure measurements were the same in both strains, but the vascular resistance of the fully dilated hindquarter bed was significantly higher in SHR than in WKY rats, with a much larger difference during maximum constriction. Plots of resistance at maximum dilatation and at maximum constriction against body weight suggest that a component of the increase in vascular muscle mass in SHR occurred in the neonatal period preceding hypertension followed by a later component related to the rise in blood pressure. By contrast, left ventricular hypertrophy was minimal at 4 weeks and most of its development paralleled the rise in blood pressure. Sympathetic activity, assessed by norepinephrine fractional rate constant, was higher in SHR than in WKY rats in the left ventricle and kidney through most of the period between 4 and 50 weeks, but was similar in both strains in the muscle bed. This pattern of sympathetic activity will accentuate hypertension once cardiac and vascular hypertrophy are fully established. In all regions, norepinephrine tissue concentration was higher in young SHR and could potentiate the trophic effects of growth factors in early vascular hypertrophy. We suggest that the initial (primary) component of vascular hypertrophy precedes the rise in blood pressure and may be critical in the pathogenesis of hypertension. Possible reasons for the short delay in the rise in blood pressure in young SHR, once the vascular "amplifier" has been established, include high vascularity, immaturity of smooth muscle, and delay in the development of left ventricular hypertrophy.


This article has been cited by other articles:


Home page
J. Physiol.Home page
A. E. Simms, J. F. R. Paton, A. E. Pickering, and A. M. Allen
Amplified respiratory-sympathetic coupling in the spontaneously hypertensive rat: does it contribute to hypertension?
J. Physiol., February 1, 2009; 587(3): 597 - 610.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
B. M. Palmer, Z. Chen, R. R. Lachapelle, E. D. Hendley, and M. M. LeWinter
Cardiomyocyte function associated with hyperactivity and/or hypertension in genetic models of LV hypertrophy
Am J Physiol Heart Circ Physiol, January 1, 2006; 290(1): H463 - H473.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
T. Fujita, Y. Toya, K. Iwatsubo, T. Onda, K. Kimura, S. Umemura, and Y. Ishikawa
Accumulation of molecules involved in {alpha}1-adrenergic signal within caveolae: caveolin expression and the development of cardiac hypertrophy
Cardiovasc Res, September 1, 2001; 51(4): 709 - 716.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
S. S. Shetty and D. DelGrande
Differential Inhibition of the Prejunctional Actions of Angiotensin II in Rat Atria by Valsartan, Irbesartan, Eprosartan, and Losartan
J. Pharmacol. Exp. Ther., July 1, 2000; 294(1): 179 - 186.
[Abstract] [Full Text]


Home page
Physiol. Rev.Home page
J. Zicha and J. Kunes
Ontogenetic Aspects of Hypertension Development: Analysis in the Rat
Physiol Rev, October 1, 1999; 79(4): 1227 - 1282.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
J.-M. Ye and E. Q. Colquhoun
Altered muscle metabolism associated with vasoconstriction in spontaneously hypertensive rats
Am J Physiol Endocrinol Metab, December 1, 1998; 275(6): E1007 - E1015.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
S. Otsuka, M. Sugano, N. Makino, S. Sawada, T. Hata, and Y. Niho
Interaction of mRNAs for Angiotensin II Type 1 and Type 2 Receptors to Vascular Remodeling in Spontaneously Hypertensive Rats
Hypertension, September 1, 1998; 32(3): 467 - 472.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
J.-M. Ye and E. Q. Colquhoun
Changes in Functional Expression of Alpha-1 Adrenoceptors in Hindlimb Vascular Bed of Spontaneously Hypertensive Rats and their Effects on Oxygen Consumption
J. Pharmacol. Exp. Ther., August 1, 1998; 286(2): 599 - 606.
[Abstract] [Full Text]


Home page
Cardiovasc ResHome page
S. A Doggrell and L. Brown
Rat models of hypertension, cardiac hypertrophy and failure
Cardiovasc Res, July 1, 1998; 39(1): 89 - 105.
[Full Text] [PDF]


Home page
HypertensionHome page
N. Makino, M. Sugano, S. Otsuka, and T. Hata
Molecular Mechanism of Angiotensin II Type I and Type II Receptors in Cardiac Hypertrophy of Spontaneously Hypertensive Rats
Hypertension, October 1, 1997; 30(4): 796 - 802.
[Abstract] [Full Text]


Home page
HypertensionHome page
S. C. Malpas, A. S. Groom, and G. A. Head
Baroreflex Control of Heart Rate and Cardiac Hypertrophy in Angiotensin II–Induced Hypertension in Rabbits
Hypertension, June 1, 1997; 29(6): 1284 - 1290.
[Abstract] [Full Text]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
D. deBlois, S.M. Schwartz, E.M. van Kleef, J.E. Su, K.A. Griffin, A.K. Bidani, M.J.A.P. Daemen, and D.M. Lombardi
Chronic {alpha}1-Adrenoreceptor Stimulation Increases DNA Synthesis in Rat Arterial Wall: Modulation of Responsiveness After Vascular Injury
Arterioscler Thromb Vasc Biol, September 1, 1996; 16(9): 1122 - 1129.
[Abstract] [Full Text]


Home page
HypertensionHome page
W. Kiowski, L. Linder, R. Nuesch, and B. Martina
Effects of Cilazapril on Vascular Structure and Function in Essential Hypertension
Hypertension, March 1, 1996; 27(3): 371 - 376.
[Abstract] [Full Text]


Home page
HypertensionHome page
A. Crambes, L. Monassier, D. Chapleau, J.-C. Roegel, J. Feldman, and P. Bousquet
GABAergic and Glutaminergic Modulation of Centrally Evoked Arrhythmias in Rats
Hypertension, January 1, 1996; 27(1): 148 - 154.
[Abstract] [Full Text]


Home page
HypertensionHome page
P. I. Korner and A. Bobik
Cardiovascular Development After Enalapril in Spontaneously Hypertensive and Wistar-Kyoto Rats
Hypertension, April 1, 1995; 25(4): 610 - 619.
[Abstract] [Full Text]


Home page
HypertensionHome page
K. Amann, H. Gharehbaghi, S. Stephan, and G. Mall
Hypertrophy and Hyperplasia of Smooth Muscle Cells of Small Intramyocardial Arteries in Spontaneously Hypertensive Rats
Hypertension, January 1, 1995; 25(1): 124 - 131.
[Abstract] [Full Text]